Novel strategy to identify MHC class II-promiscuous CD4+ peptides from tumor antigens for utilization in vaccination

Datta, J., Xu, S., Terhune, J. H., Rosemblit, C., Berk, E., Fitzpatrick, E., & Czerniecki, B. J. (2014). Novel strategy to identify MHC class II-promiscuous CD4+ peptides from tumor antigens for utilization in vaccination. Journal for ImmunoTherapy of Cancer, 2(S3). https://doi.org/10.1186/2051-1426-2-s3-p47